Two Sigma Advisers
ACER

Two Sigma Advisers’s Acer Therapeutics Inc ACER Stock Holding History

Two Sigma Advisers’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,400
Closed -$26.1K – 2800
2022
Q4 		$26.1K Sell
10,400
-1,300
-11% -$2.23K ﹤0.01% 2412
2022
Q3 		$16K Sell
11,700
-200
-2% -$290 ﹤0.01% 2458
2022
Q2 		$15K Buy
+11,900
New +$24.9K ﹤0.01% 2571
2021
Q3 		– Sell
-24,000
Closed -$69K – 2747
2021
Q2 		$69K Buy
24,000
+1,700
+8% +$4.89K ﹤0.01% 2367
2021
Q1 		$69K Buy
22,300
+500
+2% +$1.7K ﹤0.01% 2476
2020
Q4 		$57K Sell
21,800
-4,200
-16% -$11.3K ﹤0.01% 2309
2020
Q3 		$75K Buy
26,000
+11,600
+81% +$37.5K ﹤0.01% 2296
2020
Q2 		$49K Sell
14,400
-900
-6% -$2.54K ﹤0.01% 2425
2020
Q1 		$30K Sell
15,300
-2,000
-12% -$7.33K ﹤0.01% 2402
2019
Q4 		$69K Buy
17,300
+1,000
+6% +$3.4K ﹤0.01% 2275
2019
Q3 		$52K Buy
+16,300
New +$47.8K ﹤0.01% 2151

Other funds holding ACER

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MWM
Meridian Wealth Management Lexington, Kentucky $2.85B AUM 31.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers's ACER Position: Q1 2023 in Review

Two Sigma Advisers sold out of Acer Therapeutics Inc (ACER) in Q1 2023, closing a stake of 10,400 shares — an estimated $26.1K sold.

Two Sigma Advisers first reported a position in ACER in Q3 2019 and held it in 11 quarters. The position peaked at $75K in Q3 2020. 27 funds tracked by Wall St. Rank hold ACER as of Q1 2023.

  • Two Sigma Advisers reported no remaining Acer Therapeutics Inc position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 10,400 Acer Therapeutics Inc shares in Q1 2023, an estimated $26.1K.
  • Two Sigma Advisers first reported a position in Acer Therapeutics Inc in Q3 2019 and held it in 11 quarters.
  • Two Sigma Advisers's Acer Therapeutics Inc position peaked at $75K in Q3 2020.
  • 27 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q1 2023.

Based on Two Sigma Advisers's 13F filing for Q1 2023, filed 15 May 2023.